Report Categories
View AllRecent Articles
View All
PLRX Pliant Therapeutics quarterly loss narrower than feared shares tick up as pipeline hopes support sentiment
What X3 XTKG is doing that smarter investors notice Q4 2019 EPS Misses Views
CGBD Carlyle Lend posts slight Q4 2025 EPS miss edges higher as investors brush off soft results
The key driver behind Voyager Therapeutics VYGR revenue growth Q4 2025 Better Than Expected